Dallas, TX, United States of America

Scott Mendoza

This inventor holds 1 USPTO granted patent. Top assignee: AT&T Mobility. Active years: 2023.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Scott Mendoza: Innovator in Health Network Control Systems

Introduction

Scott Mendoza is an accomplished inventor based in Dallas, Texas. He has made significant contributions to the field of health network control systems, particularly through his innovative patent that leverages advanced communication technologies.

Latest Patents

Mendoza holds a patent for "Selected pre-hospital treatment based on wireless network communication in a fifth generation (5G) or other next generation network." This patent describes technologies aimed at facilitating the operation of a health network control system. The system includes a processor and memory that store executable instructions. These instructions enable the system to receive signals from a second device, analyze subject and event information, and select appropriate treatment facilities for patients.

Career Highlights

Scott Mendoza is currently employed at AT&T Mobility II LLC, where he continues to develop and refine technologies that enhance healthcare delivery. His work focuses on integrating wireless communication with health services, which is crucial for improving patient outcomes.

Collaborations

Mendoza collaborates with talented professionals in his field, including Prathima Simha and Benjamin Bell. Their combined expertise contributes to the advancement of innovative solutions in health technology.

Conclusion

Scott Mendoza's contributions to health network control systems exemplify the impact of innovation in healthcare. His patent and ongoing work at AT&T Mobility II LLC highlight the importance of technology in improving patient care and treatment efficiency.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…